VertigoADPVNCT07299487
Diagnostic Aid for Vertigo Patients
An observational study of Vertigo, run by University Hospital, Strasbourg, France at 1 site in France.
Trial summary
Consultations for vertigo in general practice are difficult, primarily due to practitioners' lack of experience. Patient referrals can be inaccurate, leading to missed opportunities or misuse of resources. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Vertigo
- How many people
- 50 participants
- Where
- 1 siteFrance
- Study dates
- 9 Sep 2024to 31 Dec 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: Adult subject having received initial care from a medical student and whose consultation data, interview, clinical examination, and diagnosis according to our decision tree were present in the patient file.
Who may be able to join
- Subject of legal age (≥18 years)
- Having received initial care from a medical student and whose consultation data, interview, clinical examination, and diagnosis according to our decision tree were present in the patient file.
- Patient for whom a definitive diagnosis was made by the on-call ENT physician during the same hospital visit.
Who cannot join
- Subject who expressed objection to the reuse of their data for scientific research.
- Known chronic vestibular pathology
- Incomplete patient medical file
- Patient examined outside the ENT department.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
Service d'ORL et de Chirurgie Cervico-faciale - CHU de Strasbourg - France
Strasbourg, 67091
Guillaume TRAU, MD, 33 3 88 12 76 44, guillaume.trau@chru-strasbourg.fr
Guillaume TRAU, MD
About this study
Official title: Evaluation of a Diagnostic Aid Tool for the Management of Vertigo Patients for General Practitioners : A Retrospective, Single-center Study at the Strasbourg University Hospital.
Consultations for vertigo in general practice are difficult, primarily due to practitioners' lack of experience. Patient referrals can be inaccurate, leading to missed opportunities or misuse of resources. The creation of a diagnostic aid flowchart that provides referrals will improve patient care and reassure general practitioners during consultations for vertigo.
- Conditions
- Vertigo
- Keywords
- Vertigo
- Medical subject headings
- Vertigo
What is being measured
The primary outcome is the main question the study is designed to answer.
Percentage of concordance between the diagnosis in the decision tree and the diagnosis made by an ENT (otolaryngologist) physician.
Measured: Up to 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Dec 2025
- Study start9 Sep 2024
- Primary completion31 Dec 2025 (estimated)
- Study completion31 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for VertigoStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Retrospective
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Strasbourg, France
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07299487
- Sponsor's protocol ID
- 9374
- Acronym
- ADPV
- Status last verified
- Dec 2025
- First submitted
- 9 Dec 2025
- Last updated
- 23 Dec 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 23 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of a Diagnostic Aid Tool for the Management of Vertigo Patients for General Practitioners : A Retrospective, Single-center Study at the Strasbourg University Hospital.
- ClinicalTrials.gov ID
- NCT07299487
- Acronym / sponsor ID
- ADPV / 9374
- Conditions
- Vertigo
- Keywords
- Vertigo
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- University Hospital, Strasbourg, FranceUniversity, hospital or other
- Study start
- 9 Sep 2024 (actual)
- Primary completion
- 31 Dec 2025 (estimated)
- Study completion
- 31 Dec 2025 (estimated)
- First posted
- 23 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Consultations for vertigo in general practice are difficult, primarily due to practitioners' lack of experience. Patient referrals can be inaccurate, leading to missed opportunities or misuse of resources. The creation of a diagnostic aid flowchart that provides referrals will improve patient care and reassure general practitioners during consultations for vertigo.
Study design
- Observational model
- Case only
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Adult subject having received initial care from a medical student and whose consultation data, interview, clinical examination, and diagnosis according to our decision tree were present in the patient file.
Key inclusion criteria (3 listed)
- Subject of legal age (≥18 years)
- Having received initial care from a medical student and whose consultation data, interview, clinical examination, and diagnosis according to our decision tree were present in the patient file.
- Patient for whom a definitive diagnosis was made by the on-call ENT physician during the same hospital visit.
Key exclusion criteria (4 listed)
- Subject who expressed objection to the reuse of their data for scientific research.
- Known chronic vestibular pathology
- Incomplete patient medical file
- Patient examined outside the ENT department.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Percentage of concordance between the diagnosis in the decision tree and the diagnosis made by an ENT (otolaryngologist) physician.
Time frame: Up to 1 year
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Dec 2025.
Related trials for Vertigo
Recruiting
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
Multiple Sclerosis
Not yet recruitingObservational study
Validation of the Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI) for Adolescents
Vestibular Migraine
RecruitingEarly Phase 1
Virtual Reality and Biofeedback for Adolescents With Chronic Dizziness
Persistent Postural Perceptual Dizziness, Vestibular Migraine
Recruiting
Effectiveness of Epley Maneuver Versus Semont Maneuver on Dizziness and Balance in Stroke Survivors With Posterior Canal BPPV
Stroke
RecruitingObservational study
Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer
Ototoxic Hearing Loss, Ototoxicity, Drug-Induced
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Vertigo, run by University Hospital, Strasbourg, France at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 23 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Guillaume TRAU, MD (33 3 88 12 76 44, guillaume.trau@chru-strasbourg.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percentage of concordance between the diagnosis in the decision tree and the diagnosis made by an ENT (otolaryngologist) physician. (time frame: Up to 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Dec 2025.